Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001503
First received: November 3, 1999
Last updated: March 14, 2014
Last verified: January 2014

November 3, 1999
March 14, 2014
May 1996
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00001503 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Follow-up for Patients Previously Enrolled on the Center for Cancer Research Protocols

This protocol is to provide follow-up medical/surgical visits for DCS patients who are long term survivors and may not currently be a participant entered on an active research protocol. No investigational treatments or standard treatments will be administered on this protocol.

Background:

Patients enrolled on CCR clinical protocols may require long term follow-up to assess outcome (e.g., survival) or the effects of prior therapy.

Keeping the primary treatment protocols open after accrual is complete in order to follow patients for long term outcome is an administrative burden on investigators and the IRB.

Objectives:

To provide follow-up for patients who are long term survivors previously enrolled Center for Cancer Research (CCR) trial but who may not currently be enrolled on a research protocol.

Eligibility:

Patients who were previously enrolled on a CCR protocol and who are not eligible for an active NCI intramural primary research protocol.

Design:

The medical procedures/tests will be based on the patient's diagnosis, treatment and supporting clinical information. This is a follow-up study in which only standard tests and procedures are to be performed.

Clinical information that is relevant to the patients prior protocols will be collected for research purposes.

Procedures that entail more than minimal risk to the patient should not be performed for research purposes on this protocol.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
  • Acquired Immunodeficiency Syndrome
  • Neoplasm
  • Skin Disease
  • HIV Infections
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1500
Not Provided
Not Provided
  • ELIGIBILITY CRITERIA:

Patients of any age who were previously enrolled on a CCR protocol.

Not eligible for or unwilling to participate in an active NCI intramural primary research protocol.

CCR investigator decides it is in the best interests of the patient and the CC for the patient to be seen in follow-up visits at the NIH.

Patient or guardian is able to provide informed consent.

Both
Not Provided
No
Contact: Caryn Steakley, R.N. (301) 435-3685 steaklec@mail.nih.gov
United States
 
NCT00001503
960071, 96-C-0071
Not Provided
Not Provided
National Cancer Institute (NCI)
Not Provided
Principal Investigator: Caryn Steakley, R.N. National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
January 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP